Welcome to LookChem.com Sign In|Join Free
  • or
Henan Allgreen Chemical Co.,Ltd110078-46-1PLERIXAFORPLERIXAFOR//file1.lookchem.com/300w/synthetic/2022-01-23-01/e72a6d98-ce03-4bed-b255-f2f949e1aff7.png

Communicate with Supplier:

Ms. Wang
Ms. Wang: What can I do for you?

110078-46-1PLERIXAFORPLERIXAFOR CAS NO.110078-46-1

Min.Order Quantity:
1 Kilogram
Purity:
99.0%
Port:
shanghai
Payment Terms:
L/C,D/A,D/P,T/T,

Add to Inquiry Cart

Product Details

Keywords

  • 110078-46-1
  • PLERIXAFOR
  • C28H54N8

Quick Details

  • ProName: 110078-46-1PLERIXAFORPLERIXAFOR
  • CasNo: 110078-46-1
  • Molecular Formula: C28H54N8
  • Appearance: White or off-white Solid
  • Application: intermediate
  • DeliveryTime: 20day
  • PackAge: According to the demand of customer
  • Port: shanghai
  • ProductionCapacity: 20 Metric Ton/Day
  • Purity: 99.0%
  • Storage: Sealed, dry, microtherm , avoid light ...
  • Transportation: According to the demand of customer
  • LimitNum: 1 Kilogram
  • Grade: Industrial Grade,Pharma Grade,Electron...

Superiority

good quality

good price

promptly delivery

Details

plerixafor basic information
product name: plerixafor
synonyms: plerixafor;1,1'-[1,4-phenylenebis(methylene)]bis-1,4,8,11-tetraazacyclotetradecane;1,4,8,11-tetraazacyclotetradecane, 1,1'-(1,4-phenylenebis(methylene))bis-;mozobil;sdz sid 791;unii-s915p5499n;1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane;plerixafor(amd3100)
cas: 110078-46-1
mf: c28h54n8
mw: 502.791
einecs:
product categories: aromatics;heterocycles;inhibitors;intermediates & fine chemicals;pharmaceuticals
mol file: 110078-46-1.mol
plerixafor structure
plerixafor chemical properties
mp 122-125°c
density 0.962
storage temp. refrigerator
safety information
msds information
plerixafor usage and synthesis
chemical properties white solid
usage plerixafor is a chemokine receptor antagonist for cxcr4 and cxcl12-mediated chemotaxis with ic50 of 44 nm and 5.7 nm, respectively
usage plerixafor is a hematopoietic stem cell (hsc) mobilizer that inhibits the cxcr4 chemokine receptor and blocks binding of its ligand, stromal cell-derived factor-1-α (sdf-1-α). on dec. 15, 2008, as treatment in combination with granulocyte-colony stimulating factor (g-csf) to mobilize hscs to the peripheral blood for collection and subsequent autologous transplantation in p atients with non-hodgkin's lymphoma (nhl) and multiple myeloma (mm).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)